Ongoing Studies

CURRENTLY ENROLLING

Atopic Dermatitis (Eczema)

MedaPhase is evaluating the safety and effectiveness of a systemic investigational medication for the treatment of Atopic Dermatitis (Eczema)

You may be qualified to participate if you:

  • Are 18 years of age or older
  • Have at least 10% body surface area affected by Atopic Dermatitis
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study.

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.

Seborrheic Keratosis

MedaPhase is evaluating the safety and effectiveness of a topical  investigational medication, or placebo, for the treatment of Seborrheic Keratosis.

You may be qualified to participate if you:

  • Are 18 years or older
  • Have at least 4 or more Seborrheic Keratoses on the face, trunk, or extremities.
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.

Rosacea

MedaPhase is evaluating the safety and effectiveness of a topical investigational medication, or placebo, for the treatment of Inflammatory Rosacea.

You may be qualified to participate if you:

  • Are 18 years or older
  • Have moderate to severe  Rosacea with a minimum of 15 inflammatory papules (red bumps)
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study.

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.

Acne

MedaPhase is evaluating the safety and effectiveness of a topical  investigational medication, or placebo, for the treatment of Acne.

You may be qualified to participate if you:

  • Are 9 years of age and older
  • Have moderate to severe Facial Acne with a minimum of 20 inflammatory papules (red bumps) on the face
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study.

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.   Participation is voluntary and you may withdraw at any time.

Psoriasis

MedaPhase is evaluating the safety and effectiveness of a topical  investigational medication, or placebo, for the treatment of Psoriasis.

You may be qualified to participate if you:

  • Are 18 years of age and older
  • Have at least 2% body surface coverage of Psoriasis.
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study.

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.   Participation is voluntary and you may withdraw at any time.

Psoriasis

MedaPhase is evaluating the safety and effectiveness of a systemic  investigational medication, or placebo, for the treatment of Psoriasis

You may be qualified to participate if you:

  • Are 18 years of age and older
  • Have at least 10% body surface coverage of Psoriasis INCLUDING scalp Psoriasis.
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study.

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.   Participation is voluntary and you may withdraw at any time.

REGISTER FOR AN ONGOING STUDY

We’re conducting studies in a variety of areas. If you’re interested in participating fill out the form below or click the indication to learn more.

Full Name*

Email*

Phone Number*

Zip Code*

Preferred method of contact: PhoneEmail

Check the skin conditions that apply to you:
AcneActinic KeratosisAtopic DermatitisEczemaMolluscumMale Pattern Hair LossOnychomycosisPsoriasisRosaceaSkin CancerWartsOther

Message: